An Activist Investor Is Interested in CVS; We Take a Look

In This Article:

In this podcast, Motley Fool analyst Seth Jayson and host Dylan Lewis discuss:

  • Why CVS has activists sniffing around, and how getting the insurance operations right could get the company and the stock back in motion.

  • How interest rates are affecting the housing and auto markets, and other updates from KB Homes and CarMax.

Motley Fool analyst Jason Moser and host Mary Long look at Uber, and its quest to become the everything app.

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our beginner's guide to investing in stocks. A full transcript follows the video.

Should you invest $1,000 in CVS Health right now?

Before you buy stock in CVS Health, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CVS Health wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $752,838!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.

See the 10 stocks ?

*Stock Advisor returns as of September 30, 2024

This video was recorded on Sept. 30, 2024.

Dylan Lewis: We're checking in on the way rates are hitting home and autos. Motley Fool Money starts now. I'm Dylan Lewis, and I'm joined over the airwaves by Motley Fool analyst Seth Jayson. Seth thanks for joining me.

Seth Jayson: Yeah.

Dylan Lewis: We've got another activist in the wings, and we are catching up on housing and car market data and earnings reports. Seth, as we talk here today, leadership at CVS has some visitors from Glenview Capital. The hedge fund reportedly has built up a decent stake in CVS and has some ideas for the company's management team. Sounds an awful lot like we might be looking at another activist investor here.

Seth Jayson: It's one of those stories where we get this big headline, and I guess it's the Wall Street Journal, which is then quoted all over the place. You look and there's no details of any kind. What they might want, what would you do to CVS? I haven't looked at CVS as a company for a while, so it was fun to dig in a little and see what an interesting mess it is, especially for me this weekend because I had a couple of very interesting CVS experiences as a consumer regarding the front of the store, which is one of the problems they're having. The front of the store is the non-pharmacy stuff. It's the chips and all of that stuff.